By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioTime, Inc. 

1301 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-521-3390 Fax: 510-521-3389


Company News
BioTime (BTX) Co-CEO Dr. Michael West Presents At Biomedical Innovation For Healthy Longevity, International Conference 4/26/2016 12:13:06 PM
BioTime (BTX) Co-CEO Dr. Michael West To Present At Stem Cells In Drug Discovery 2016 In Cambridge, UK 4/5/2016 9:12:40 AM
BioTime (BTX) To Host Conference Call To Update Investors On Recent Accomplishments And Corporate Objectives For 2016 3/21/2016 10:25:16 AM
BioTime (BTX) Subsidiary Asterias Biotherapeutics Reports The Successful End-Of-Phase II FDA Meeting For Immunotherapy In Acute Myeloid Leukemia 2/24/2016 11:28:10 AM
BioTime (BTX) And Asterias Biotherapeutics Sign Share Transfer Agreement And Cross-License Agreement For Pluripotent Stem Cell Related Patents 2/17/2016 11:32:41 AM
BioTime (BTX) To Present At Three Investor Conferences In February 2/2/2016 11:04:35 AM
LifeMap Sciences, A Subsidiary Of BioTime (BTX), Announces The Launch Of TGex, The Knowledge-Driven NGS Analysis Platform, Powered By The Genecards Suite 1/20/2016 8:15:46 AM
Adjustments Affecting BioTime (BTX) Common Share Purchase Warrants Expiring October 1, 2018 1/13/2016 11:06:21 AM
BioTime (BTX) Completes Distribution Of Approximately 4.75 Million Shares Of OncoCyte Corporation Common Stock 12/31/2015 8:05:08 AM
BioTime (BTX) Announces "When-Issued" Trading Of Subsidiary OncoCyte Corporation In Connection With Planned Distribution 12/30/2015 9:24:32 AM